Literature DB >> 23374534

Fatal cutaneous anthrax in a heroin user.

S Meghji1, O Judd, E Carr.   

Abstract

BACKGROUND AND
OBJECTIVE: Cutaneous anthrax usually has a mortality rate of less than 1 per cent. However, since December 2009 there have been more than 13 deaths in the UK due to anthrax-contaminated heroin. We therefore wish to raise clinical awareness of this treatable disease. CASE REPORT: We describe the case of a heroin user with an equivocal presentation of cellulitis in the neck. Within 36 hours, this led to death due to cutaneous anthrax.
CONCLUSION: Whilst cutaneous anthrax remains rare, this case report aims to raise awareness of the fact that the symptoms and signs of this condition in intravenous drug users may not always fit the typical picture.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374534     DOI: 10.1017/S0022215112003210

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Injectional anthrax at a Scottish district general hospital.

Authors:  D J Inverarity; V M Forrester; J G R Cumming; P J Paterson; R J Campbell; T J G Brooks; G L Carson; J P Ruddy
Journal:  Epidemiol Infect       Date:  2014-07-31       Impact factor: 4.434

2.  Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis.

Authors:  Karen E Kempsell; Stephen P Kidd; Kuiama Lewandowski; Michael J Elmore; Sue Charlton; Annemarie Yeates; Hannah Cuthbertson; Bassam Hallis; Daniel M Altmann; Mitch Rogers; Pierre Wattiau; Rebecca J Ingram; Tim Brooks; Richard Vipond
Journal:  Front Microbiol       Date:  2015-08-13       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.